
NORTH CHICAGO, Illinois — Walgreens Boots Alliance Inc (WBA.O), the owner of the Walgreens drugstore chain, reported weaker-than-expected quarterly results on Friday and gave a disappointing forecast, sending its shares down 6%.
The company said net income fell to $380 million, or $1.08 per share, in the quarter ended May 31, from $669 million, or $1.89 per share, a year earlier. Analysts on average had expected earnings of $1.10 per share, according to Refinitiv data.
Walgreens said U.S. pharmacy sales declined 3.9% due to lower sales of generic drugs and a shift in business from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. fell 2.3%.
The company's shares were down 6% at $44.60 in morning trading.
Walgreens also said it expects full-year earnings to be between $4.30 and $4.45 per share, below analysts' average estimate of $4.47 per share.
The results come as Walgreens continues to face pressure from competition in the pharmacy sector, particularly from Amazon.com Inc (AMZN.O), which has been expanding its own pharmacy services.
Walgreens Chairman and Chief Executive Officer Doug McMillon said the company is "executing against our strategic priorities" but acknowledged that "the macro environment remains challenging." (Reporting by Sanjana Sastry in Boston; Editing by Will Dunham and Nick Zieminski)
崾 complains of unsatisfactory quarterly performance and lowered its outlook, causing its shares to drop 6%.
Walgreens reported a net income of $380 million, or $1.08 per share, for the quarter ended May 31, down from $669 million, or $1.89 per share, in the same period a year earlier.
The company attributed the decline to lower U.S. pharmacy sales, which fell 3.9% due to decreased sales of generic drugs and a shift from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. decreased by 2.3%.
Walgreens also announced an outlook for full-year earnings between $4.30 and $4.45 per share, below the analysts' average estimate of $4.47 per share.
The company faces ongoing pressure from competitors like Amazon, which has been expanding its pharmacy services.
Walgreens Chairman and CEO Doug McMillon stated, "We are executing against our strategic priorities," but acknowledged the challenging macro environment.
Shares of Walgreens were trading down 6% at $44.60 in morning trading.
Walgreens #QuarterlyResults #EarningsReport #StockMarket #RetailPerformance
不止跳舞!宇树机器人轻松拿捏平衡木、梅花桩
科创板日报
中方包机接回从缅甸电诈园区遣返的中国籍人员
人民日报客户端
骑手缴纳社保,外卖会变贵吗?网友:这是我最关心的
每日经济新闻
鳌太线失联10天亲历者:铺树叶裸睡一晚,把牙膏当糖吃
潇湘晨报
Deepseek测出理想伴侣仅存个位数?别慌!赛博月老只懂数据,不懂爱情
纵览新闻
“事情已解决”房东猥亵女租客因超70岁不执行拘留,女子男友最新回应
大河报
著名球迷“退钱哥”加盟中冠新疆球队?本人回应:属实,想圆足球梦
上游新闻
@纳税人 这笔钱别忘领!2024年度个税汇算明日起预约
央视新闻客户端
菲方飞机带外国记者闯入黄岩岛!证据公布
玉渊谭天
饿了么:2023年起已启动骑手社保缴纳试点
九派新闻